terazosin has been researched along with Kidney Failure, Chronic in 2 studies
Terazosin: induces decreased blood pressure; used in the treatment of benign prostatic hyperplasia
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Terazosin is a new, long-acting, selective, postsynaptic alpha 1-adrenergic receptor antagonist with a chemical structure similar to that of prazosin." | 2.38 | Terazosin: pharmacokinetics and the effect of age and dose on the incidence of adverse events. ( Achari, R; Laddu, AR; Somberg, JC, 1991) |
| " The plasma half-life of terazosin in patients with normal renal function was 10." | 1.27 | Influence of renal insufficiency on the pharmacokinetics and pharmacodynamics of terazosin. ( Chauveau, P; Ganeval, D; Jungers, P; Pertuiset, N, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Somberg, JC | 1 |
| Achari, R | 1 |
| Laddu, AR | 1 |
| Jungers, P | 1 |
| Ganeval, D | 1 |
| Pertuiset, N | 1 |
| Chauveau, P | 1 |
1 review available for terazosin and Kidney Failure, Chronic
| Article | Year |
|---|---|
Terazosin: pharmacokinetics and the effect of age and dose on the incidence of adverse events.
Topics: Adrenergic alpha-Antagonists; Age Factors; Antihypertensive Agents; Dose-Response Relationship, Drug | 1991 |
1 other study available for terazosin and Kidney Failure, Chronic
| Article | Year |
|---|---|
Influence of renal insufficiency on the pharmacokinetics and pharmacodynamics of terazosin.
Topics: Adrenergic alpha-Antagonists; Adult; Blood Pressure; Female; Half-Life; Humans; Kidney Failure, Chro | 1986 |